Consequently, high expression of CD73 boosts the metabolic activity of gastric cancer cells and supports immune suppression and invasion, allowing tumor cells to grow and metastasize in hostile microenvironments, making CD73 a potential therapeutic target for gastric cancer. Here, NT5E is linked to neoplasm.